Up merger monday from big pharma to finance. The appetite for deals kicking in all around the world. And disney doing something this year that no other studio has ever done before, oh, yeah, we still got five months to go in the year. So grab your eticket. Its monday, july 29th, Worldwide Exchange begins right now. Y good morning, good afternoon, good evening and welcome from wherever in the world you may be watching im Brian Sullivan so happy to be back with you especially on this very busy monday bind us, shares of mylan labs, myl, stock is up 27 in the market deal with pfizer for their generic drug business may be eminent. Without this mornings move, shares of mylan were down. Th this reverse that. That will be your stock and your deal of the day. Well get more on mylan and pfizer in just a minute. Macro perspective, here is how your week is setting up right now. Futures not giving us a lot of indication about this market so far. Lets call it down 15. Lets call it flat to be generou
Merger deal with pfizers generics unit. And disney domination. The studio breaking an alltime record for annual box office earnings, and of course, it is only july. So, theres a lot for investors to digest this week with stocks at record highs. Jim, coming off of those on friday, you were out, but a lot happened good to have you back. Thank you the starbucks calls kind of the emblematic of what happened this quarter. Starbucks had run big. So you had to figure, no matter what, how could it really move then it goes up big dollars because its better than expected, better than feared what were seeing are companies that we were worried about because stocks have run, and then the stocks do okay. So, this is a short sellers dilemma. Lets say youve been betting against companies because you truly believe theres been an earnings deceleration. If earnings just stay in line, the stock flies. If earnings are a little bit below, the stock doesnt do anything. Right. So, theres just this kind of bid
To report. Also trade representatives set to kick off a new round of china talks in shanghai. Earnings less than an hour away, well preview the key things to watch from that report with the stock up 800 on this 25 ipo price. Steve grasso from stewart frank, and a lot of moving parts, what do you do . It feels as if everyones on hold for the fed thats the most important thing thats happening right now earnings this surprised to the upside everyone usually, even last quarter, even was ready for a a into the earnings cycle. Steve is here with us for the full hour, and well be dissecting the market moves. Lets focus on the big stories the pharma deal, more fallout for boeing, and eamon javers. Viagra, lipitor, xanax and the epipen, pfizer is going to spin off or divest its up patent business and combine with mylan, and the new company will do about 20 billion in annual sales. It will get a new name and be domicile in the United States, a fact that could be attributed to u. S. Tax reform an
Minute look at quick u. S. Equity futures at this hour show you how things look to be opening up in about 3 1 2 hours from now dow would be off about 20 points nasdaq looking to open up 15 points s p 500 looking to open off a little off well call it 3 1 2 points right now and also show you whats happening overnight in asia right now as we speak. Youre looking at red arrows across the board but well call it marginal except for the hang sang take a quick look at european equities as well as we flip that board around youre looking at mostly red picture, except the ftse 100 looking up 1 right now and finally treasury yields, tenyear notes unless youre looking for a 30year fixed right now the tenyear note is at 2. 060 joe . Big deal of the morning. Big. Big. Mylan, potential pharma deal to tell you about. Unit of pfizer with mylan. Thats right. Were expecting this news to be announced sometime this morning. What were hearing is that pfizer plans to spin off a unit called up john, off patent
Featuring members of the aspen Economic Strategy group. Big thanks to our society of fellows and community of donors for supporting our programming and your engagement all summer long. We cant do it without you. Thank you so much for your support. [applause] i dont know if they are here yet, but a big thanks to tom and bonnie for their support of the institute and for endowing the fletcher series. [applause] its my pleasure to introduce our speakers and thank them for being here. First, to my immediate right is rob portman. Rob is a former u. S. Senator from ohio, distinguished visiting fellow at the american in Price Institute American Enterprise institute. His career spans three decades including three president ial administrations and two terms in the United States senate and six terms in the United States house of representatives. Thank you, senator portman, for being with us. [applause] to senator portmans right is cecilia rouse, who previously served as chair of the council of ec